title: Multiple lentigines confined to resolving psoriatic plaques in a patient treated with adalimumab.
authors.forename: Jorge
authors.initials: J
authors.lastname: Santos-Juanes
authors.forename: Pablo
authors.initials: P
authors.lastname: Coto
authors.forename: Susana
authors.initials: S
authors.lastname: Mallo
authors.forename: Cristina
authors.initials: C
authors.lastname: Galache
authors.forename: José
authors.initials: J
authors.lastname: Sánchez del Río
authors.forename: J C
authors.initials: JC
authors.lastname: Torre
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D007911:Lentigo / Q000209:etiology* / Q000473:pathology; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy; D012867:Skin / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D000068879:Adalimumab